ProShare Advisors Portfolio holdings
AUM
$47.8B
1-Year Est. Return
25.01%
1 Year Est. Return
+25.01%
AUM
$47.8B
AUM Growth
-$2.34B
(-4.7%)
Holding
2,131
Top Buys
| 1 | +$75.8M | |
| 2 | +$65.3M | |
| 3 | +$32.6M | |
| 4 |
Brown & Brown
BRO
|
+$27.5M |
| 5 |
Consolidated Edison
ED
|
+$24.7M |
Top Sells
| 1 | +$670M | |
| 2 | +$466M | |
| 3 | +$461M | |
| 4 |
Broadcom
AVGO
|
+$341M |
| 5 |
Amazon
AMZN
|
+$262M |
Sector Composition
| 1 | Technology | 35.22% |
| 2 | Consumer Discretionary | 10.23% |
| 3 | Industrials | 9.48% |
| 4 | Communication Services | 9.26% |
| 5 | Financials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Oric Pharmaceuticals
ORIC
$888M
| $161K | ﹤0.01% |
13,383
+1,527
|
|
||
1752
QuinStreet
QNST
$830M
| $159K | ﹤0.01% |
10,296
-1,896
|
|
||
1753
Geron
GERN
$855M
| $159K | ﹤0.01% |
116,136
-32,131
|
|
||
1754
Nuvation Bio
NUVB
$2.97B
| $158K | ﹤0.01% |
42,675
-8,501
|
|
||
1755
SFL Corp
SFL
$1.1B
| $156K | ﹤0.01% |
20,747
-4,135
|
|
||
1756
Embecta
EMBC
$696M
| $156K | ﹤0.01% |
11,024
-2,037
|
|
||
1757
NextDecade
NEXT
$1.35B
| $155K | ﹤0.01% |
22,881
-4,558
|
|
||
1758
Immunome
IMNM
$2.15B
| $155K | ﹤0.01% |
13,194
-1,913
|
|
||
1759
Anavex Life Sciences
AVXL
$359M
| $154K | ﹤0.01% |
17,354
-2,976
|
|
||
|
ORC
1760
Orchid Island Capital
ORC
$1.22B
| $154K | ﹤0.01% |
21,909
-207
|
|
||
1761
Tandem Diabetes Care
TNDM
$1.53B
| $153K | ﹤0.01% |
12,606
-2,313
|
|
||
1762
Flushing Financial
FFIC
$586M
| $152K | ﹤0.01% |
+11,028
|
|
||
1763
Hertz
HTZ
$1.59B
| $152K | ﹤0.01% |
22,361
-4,108
|
|
||
|
NPKI
1764
NPK International
NPKI
$1.07B
| $152K | ﹤0.01% |
13,428
-3,063
|
|
||
1765
Red Cat Holdings
RCAT
$880M
| $151K | ﹤0.01% |
14,605
-749
|
|
||
1766
Taysha Gene Therapies
TSHA
$1.59B
| $151K | ﹤0.01% |
46,039
+2,293
|
|
||
1767
Utz Brands
UTZ
$930M
| $150K | ﹤0.01% |
12,383
-2,466
|
|
||
1768
Relay Therapeutics
RLAY
$1.47B
| $150K | ﹤0.01% |
28,776
-4,781
|
|
||
1769
ThredUp
TDUP
$964M
| $149K | ﹤0.01% |
15,812
-2,846
|
|
||
1770
Kura Oncology
KURA
$925M
| $149K | ﹤0.01% |
16,880
-2,569
|
|
||
1771
Evolv Technologies
EVLV
$1.2B
| $149K | ﹤0.01% |
19,774
-3,941
|
|
||
1772
Arbutus Biopharma
ABUS
$883M
| $149K | ﹤0.01% |
32,715
-5,480
|
|
||
1773
Yext
YEXT
$1.04B
| $148K | ﹤0.01% |
17,355
-3,830
|
|
||
1774
Capitol Federal Financial
CFFN
$918M
| $147K | ﹤0.01% |
23,196
-4,289
|
|
||
1775
3D Systems Corp
DDD
$246M
| $147K | ﹤0.01% |
50,705
-3,721
|
|